Sens. Introduce Revised Drug Compounding Bill

Law360, New York (July 25, 2013, 6:08 PM EDT) -- U.S. senators on Thursday unveiled several revisions to legislation that would overhaul regulation of compounding pharmacies in response to a deadly meningitis outbreak, clarifying the types of drugs that can’t be compounded and making it easier for compounders to alleviate drug shortages.

The tweaks were introduced two months after the Senate Health, Education, Labor and Pensions Committee unanimously advanced the bill, which was prompted by the deaths of more than 60 people who received allegedly tainted steroid injections from a Massachusetts compounder. In some respects the changes...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.